首页 › 基金 › SILVERARC CAPITAL MANAGEMENT, LLC › ABVX

SILVERARC CAPITAL MANAGEMENT, LLC 对 ABVX 的持仓历史

ABIVAX SA · 医疗保健

SILVERARC CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 ABVX(ABIVAX SA)175,699 股,市值约 US$17.4M,约占其申报组合的 2.22%,在其申报持仓中市值排名第 14 位。 SILVERARC CAPITAL MANAGEMENT, LLC 最近 11 个申报季度中有 10 个季度披露了 ABVX 持仓,最早可追溯至 Q1 2024。

最新持仓 (Q3 2026)175.70K 股
申报持仓市值$17.40M
组合权重2.22%
首次申报Q1 2024
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

SILVERARC CAPITAL MANAGEMENT, LLC 对 ABVX 的持仓演变

SILVERARC CAPITAL MANAGEMENT, LLC 于 Q1 2024 首次披露 ABVX 持仓:75,000 股(约 US$1.1M)。 该持仓在 Q4 2025 达到峰值 422,193 股,市值约 US$56.9M。 在 10 次申报中,SILVERARC CAPITAL MANAGEMENT, LLC 3 次增持、5 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 175,699 股、市值约 US$17.4M,环比增持 125,699 股。。 持仓曾出现大幅变动:Q2 2024 增持约 508% (随后一个季度股价下跌 13%)、Q2 2026 减持约 83% (随后一个季度股价下跌 26%)、Q3 2026 增持约 251% (随后一个季度股价下跌 12%)。

逐季持仓明细

季度股数金额变化
Q1 2024 75.00K $1.07M 新进
Q2 2024 455.80K $6.03M 增持
Q3 2024 461.66K $5.32M 增持
Q4 2024 285.12K $2.09M 减持
Q1 2025 210.90K $1.32M 减持
Q3 2025 539.70K $45.82M 新进
Q4 2025 422.19K $56.93M 减持
Q1 2026 302.53K $33.69M 减持
Q2 2026 50.00K $6.66M 减持
Q3 2026 175.70K $17.40M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABVX 与 13F 数据

ABVX(ABIVAX SA)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 ABVX,申报仓位最大的包括:TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABVX 的基金

查看 ABVX 的全部基金持有人 →

常见问题

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ABVX?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ABVX holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ABVX?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 175.70K shares of ABVX (ABIVAX SA), valued at $17.40M, representing 2.22% of its reported portfolio and ranking #14.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ABVX?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in ABVX. The position peaked in Q4 2025 at 422.19K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.